Volume 15, Issue 10 (January 2022)
Qom Univ Med Sci J 2022, 15(10): 726-735 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Davarinejad O, Mohammadi Majd T, Abbasi M, Eskandari S. Identification of Effective Factors in Recurrence of Schizophrenia Spectrum Disorder Using Poisson Regression Model. Qom Univ Med Sci J 2022; 15 (10) :726-735
URL: http://journal.muq.ac.ir/article-1-3334-en.html
URL: http://journal.muq.ac.ir/article-1-3334-en.html
1- Department of Psychiatry, Faculty of Medical, Development Center Clinical Research, Imam Khomeini, Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Department of Biostatistics, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Department of Health Information Technology, Faculty of Paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran ,abbasi.info89@yahoo.com
4- Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Department of Biostatistics, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Department of Health Information Technology, Faculty of Paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran ,
4- Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract: (1624 Views)
Background and Objectives: Schizophrenia is one of the most severe psychiatric disorders that has a recurrent nature. Frequent relapses have destructive impacts on patient’s thoughts, behaviors and relationships. These can lead to disruption of personal and social performance of patient. The aim of this study was to identify risk factors for increasing the number of relapses.
Methods: In this retrospective cohort study, data from medical records of individuals with SSD who were admitted at least once to Farabi Hospital between 2015 and 2019 years extracted. To determine factors related to recurrence of Schizophrenia, Univariate and multivariate analysis and multivariate Poisson Regression were performed respectively. Analysis was done using STATA 14.1.
Results: Based on extracted data from 401 medical records, 255 (63.6%) were males and 146 (36.4%) were females. A total of 1105 relapse were observed in males with 683 cases, and females with 422 cases. 65 patient experienced relapse from 5 to 11 times. Among considered variables, Employment status (RR=0.85, P-value=0.043), age (RR=0.99, P-value=0.03), Mode of Onset (RR=0.78, P-value=0.027) and Medication Adherence (RR=1.67, P<0.001) were significant on increasing readmission.
Conclusion: According to the results of this study, the young age of onset of schizophrenia, the gradual onset of the disorder, unemployment and drug non-compliance had a significant effect on increasing the risk of recurrence in patients with schizophrenia. considering above risk factors, it seems necessary to perform preventive and therapeutic measures to reduce the risk of relapses. Patients with non-adherence can be under education and counseling.
Methods: In this retrospective cohort study, data from medical records of individuals with SSD who were admitted at least once to Farabi Hospital between 2015 and 2019 years extracted. To determine factors related to recurrence of Schizophrenia, Univariate and multivariate analysis and multivariate Poisson Regression were performed respectively. Analysis was done using STATA 14.1.
Results: Based on extracted data from 401 medical records, 255 (63.6%) were males and 146 (36.4%) were females. A total of 1105 relapse were observed in males with 683 cases, and females with 422 cases. 65 patient experienced relapse from 5 to 11 times. Among considered variables, Employment status (RR=0.85, P-value=0.043), age (RR=0.99, P-value=0.03), Mode of Onset (RR=0.78, P-value=0.027) and Medication Adherence (RR=1.67, P<0.001) were significant on increasing readmission.
Conclusion: According to the results of this study, the young age of onset of schizophrenia, the gradual onset of the disorder, unemployment and drug non-compliance had a significant effect on increasing the risk of recurrence in patients with schizophrenia. considering above risk factors, it seems necessary to perform preventive and therapeutic measures to reduce the risk of relapses. Patients with non-adherence can be under education and counseling.
Type of Study: Original Article |
Subject:
روانپزشک
Received: 2021/12/9 | Accepted: 2021/12/28 | Published: 2022/01/30
Received: 2021/12/9 | Accepted: 2021/12/28 | Published: 2022/01/30
References
1. Sadock BJ, Sadock VA, Ruiz P. Comprehensive textbook of psychiatry. Lippincott Williams & Wilkins Philadelphia; 2000. https://www.google.com/books/edition/Kaplan_Sadock_s_Comprehensive_Textbook_o/m0YbQgAACAAJ?hl=en
2. Carpenter WT, Tandon R. Psychotic disorders in DSM-5: Summary of changes. Asian J Psychiatry. 2013; 6(3):266-8. [DOI:10.1016/j.ajp.2013.04.001] [PMID] [DOI:10.1016/j.ajp.2013.04.001]
3. American Psychiatric Publishing (APA). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Publishing. 2013. [DOI:10.1176/appi.books.9780890425787] [DOI:10.1176/appi.books.9780890425787]
4. Aleman A, Kahn RS, Selten J-P. Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Arch Gen Psychiatry. 2003; 60(6):565-71. [DOI:10.1001/archpsyc.60.6.565] [PMID] [DOI:10.1001/archpsyc.60.6.565]
5. Lewis G. DSM-IV. Diagnostic and Statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 1994. [DOI:10.1017/S0033291700035765] [DOI:10.1017/S0033291700035765]
6. Madaan V, Dvir Y, Wilson DR. Child and adolescent schizophrenia: Pharmacological approaches. Expert Opin Pharmacother. 2008; 9(12):2053-68. [DOI:10.1517/14656566.9.12.2053] [PMID] [DOI:10.1517/14656566.9.12.2053]
7. Boyd MA. Psychiatric Nursing: Contemporary practice. Lippincott Williams & Wilkins; 2008. https://www.google.com/books/edition/Psychiatric_Nursing/3UUuXw7ISM0C?hl=en&gbpv=0
8. Noorbala A, Mohammad K, Bagheri Yazdi E, Yasemi M. Survey of mental health of adolescents and adults in Islamic republic of Iran. Hakim Res J. 2002;5(1):1-10.
9. Ranjbar F, Ghanbari B, Khaleghparast S, Manouchehri H, Nasiri N. The effects of discharge planning on insight, symptoms and hospitalization of schizophrenia patients at Iran University of Medical Sciences Hospitals. Iran J Psychiatr Clin Psychol. 2011; 17(1):53-9. https://ijpcp.iums.ac.ir/article-1-1317-en.html
10. Robinson D, Woerner MG, Alvir JMJ, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999; 56(3):241-7. [DOI:10.1001/archpsyc.56.3.241] [PMID] [DOI:10.1001/archpsyc.56.3.241]
11. Khankeh H. [Effect of education and follow up (discharge planning) on self care ability, symptoms and hospital stay of chronic Schizophrenics in Razy hospital [Msc Thesis] (Persian)]. Tehran: Rehabilitation Welfare University; 2007.
12. Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: Costs, clinical outcomes and quality of life. The British Journal of Psychiatry. 2004; 184(4):346-51. [DOI:10.1192/bjp.184.4.346] [PMID] [DOI:10.1192/bjp.184.4.346]
13. Kane JM. Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry. 2007; 68(Suppl 14):27-30. [PMID]
14. Lieberman JA, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, et al. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology. 1996; 14(3):13S-21S. [DOI:10.1016/0893-133X(95)00200-W] [DOI:10.1016/0893-133X(95)00200-W]
15. Wyatt RJ. Research in schizophrenia and the discontinuation of antipsychotic medications. Schizophr Bull. 1997; 23(1):3-9. [DOI:10.1093/schbul/23.1.3] [PMID] [DOI:10.1093/schbul/23.1.3]
16. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, et al. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry. 1999; 56(2):162-8. [DOI:10.1001/archpsyc.56.2.162] [PMID] [DOI:10.1001/archpsyc.56.2.162]
17. Gottesman II. Schizophrenia genesis: The origins of madness: WH Freeman/Times Books/Henry Holt & Co; 1991. https://www.google.com/books/edition/Schizophrenia_Genesis/V9BitAEACAAJ?hl=en
18. Cannon M, Jones P. Schizophrenia. J Neurol Neurosurg Psychiatry. 1996; 60(6):604-13. [DOI:10.1136/jnnp.60.6.604] [PMID] [PMCID] [DOI:10.1136/jnnp.60.6.604]
19. Tienari P, Wynne LC, Sorri A, Lahti I, Läksy K, Moring J, et al. Genotype-environment interaction in schizophrenia-spectrum disorder: Long-term follow-up study of Finnish adoptees. Br J Psychiatry. 2004; 184(3):216-22. [DOI:10.1192/bjp.184.3.216] [PMID] [DOI:10.1192/bjp.184.3.216]
20. Tamizi Z, Ranjbar F, Yaghmaee F, Alavimajd H, Fallahi Khoshknab M. Assessment of relationship between quality of life and coping strategies in schizophrenic patients in refer to psychiatric clinics of educational hospitals of Tehran. J Rehabil. 2013; 13(4):124-31. https://www.researchgate.net/publication/236658228_Assessment_of_Relationship
21. Rahmati M, Rahgozar M, Fadaei F, Bakhshi E, Cheraghi L. Identifying some risk factors of time to relapses in schizophrenic patients using Bayesian approach with event-dependent frailty model. Iran J Psychiatry. 2015; 10(2):123-7. [PMID] [PMCID]
22. Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. [DOI:10.1111/j.1751-7176.2008.07572.x] [PMID] [PMCID] [DOI:10.1111/j.1751-7176.2008.07572.x]
23. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986:67-74. [DOI:10.1097/00005650-198601000-00007] [PMID] [DOI:10.1097/00005650-198601000-00007]
24. McCullagh P, Nelder J. Generalized linear models., 2nd edition. (Chapman and Hall: London). Standard book on generalized linear models. 1989. [DOI:10.1007/978-1-4899-3242-6] [PMCID] [DOI:10.1007/978-1-4899-3242-6]
25. Marrone J, Golowka E. If work makes people with mental illness sick, what do unemployment, poverty, and social isolation cause? Psychiatr Rehabil J. 1999; 23(2):187. [DOI:10.1037/h0095171] [DOI:10.1037/h0095171]
26. Luciano A, Metcalfe JD, Bond GR, Xie H, Miller AL, Riley J, et al. Hospitalization risk before and after employment among adults with schizophrenia, bipolar disorder, or major depression. Psychiatric Services. 2016; 67(10):1131-8. [DOI:10.1176/appi.ps.201500343] [PMID] [DOI:10.1176/appi.ps.201500343]
27. Luciano A, Bond GR, Drake RE. Does employment alter the course and outcome of schizophrenia and other severe mental illnesses? A systematic review of longitudinal research. Schizophr Res. 2014; 159(2-3):312-21. [DOI:10.1016/j.schres.2014.09.010] [PMID] [DOI:10.1016/j.schres.2014.09.010]
28. Jørgensen P. Social course and outcome of delusional psychosis. Acta Psychiatr Scand. 1987; 75(6):629-34. [DOI:10.1111/j.1600-0447.1987.tb02847.x] [PMID] [DOI:10.1111/j.1600-0447.1987.tb02847.x]
29. Dongen CJV. Self-esteem among persons with severe mental illness. Issues Ment Health Nurs. 1998; 19(1):29-40. [DOI:10.1080/016128498249196] [PMID] [DOI:10.1080/016128498249196]
30. Yamaguchi S, Mino Y, Uddin S. Strategies and future attempts to reduce stigmatization and increase awareness of mental health problems among young people: A narrative review of educational interventions. Psychiatry Clin Neurosci. 2011; 65(5):405-15. [DOI:10.1111/j.1440-1819.2011.02239.x] [PMID] [DOI:10.1111/j.1440-1819.2011.02239.x]
31. Provencher HL, Gregg R, Mead S, Mueser KT. The role of work in the recovery of persons with psychiatric disabilities. Psychiatr Rehabil J. 2002; 26(2):132. [DOI:10.2975/26.2002.132.144] [PMID] [DOI:10.2975/26.2002.132.144]
32. Jahoda M. Work, employment, and unemployment: Values, theories, and approaches in social research. Am Psycholo. 1981; 36(2):184. [DOI:10.1037/0003-066X.36.2.184] [DOI:10.1037/0003-066X.36.2.184]
33. Immonen J, Jääskeläinen E, Korpela H, Miettunen J. Age at onset and the outcomes of schizophrenia: A systematic review and meta‐analysis. Early interv Psychiatry. 2017; 11(6):453-60. [DOI:10.1111/eip.12412] [PMID] [PMCID] [DOI:10.1111/eip.12412]
34. Cheraghi L, Rahgozar M, Fadaei F, Karimlou M, Biglarian A. Time to Recurrent Relapses Analysis in Schizophrenic Patients by Using Recurrent Events Model. Arch Rehabil. 2013; 13(4):65-71. https://rehabilitationj.uswr.ac.ir/article-1-898-en.html
35. Lin C-H, Chen M-C, Chou L-S, Lin C-H, Chen C-C, Lane H-Y. Time to rehospitalization in patients with major depression vs. those with schizophrenia or bipolar I disorder in a public psychiatric hospital. Psychiatry Res. 2010; 180(2-3):74-9. [DOI:10.1016/j.psychres.2009.12.003] [PMID] [DOI:10.1016/j.psychres.2009.12.003]
36. Marder SR. Overview of partial compliance. The Journal of clinical psychiatry. 2003; 64(Suppl 16):3-9. [PMID]
37. Lindenmayer J-P, Liu-Seifert H, Kulkarni PM, Kinon BJ, Stauffer V, Edwards SE, et al. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry. 2009; 70(7):990-6. [DOI:10.4088/JCP.08m04221] [PMID] [DOI:10.4088/JCP.08m04221]
38. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998; 49(2):196-201. [DOI:10.1176/ps.49.2.196] [PMID] [DOI:10.1176/ps.49.2.196]
39. Lingam R, Scott J. Treatment non‐adherence in affective disorders. Acta Psychiatr Scand. 2002; 105(3):164-72. [DOI:10.1034/j.1600-0447.2002.1r084.x] [PMID] [DOI:10.1034/j.1600-0447.2002.1r084.x]
40. Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010; 176(2-3):109-13. [DOI:10.1016/j.psychres.2009.05.004] [PMID] [DOI:10.1016/j.psychres.2009.05.004]
41. Schumann C, Lenz G, Berghöfer A, Müller-Oerlinghausen B. Non-adherence with long-term prophylaxis: A 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res. 1999; 89(3):247-57. [DOI:10.1016/S0165-1781(99)00108-0] [DOI:10.1016/S0165-1781(99)00108-0]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
